Ziteo Medical will introduce its breakthrough high-definition (HD) SPECT technology to the SNMMI Community at Booth 1808.
Ziteo is redefining the limits of molecular imaging with its pioneering HD SPECT technology. The company will unveil its first clinical images showcasing unparalleled image quality and exceptional resolution.
Building on its innovative HD SPECT platform, Ziteo aims to further revolutionize patient care by integrating real-time image fusion between molecular and ultrasound imaging to bridge the gap between diagnosis and intervention. This image fusion aims to enable clinicians to perform biopsies and ablations with extraordinary precision, guided by the dual insights of ultrasound, for anatomical views, and molecular imaging, for highlighting target lesions.
Join us to see these breakthrough images, hear about our product plans, and discuss how HD SPECT could help you improve patient care.
Ziteo is a privately held company based in the San Francisco Bay Area and is backed by venture capital firms.
Please visit www.ziteo.com or contact us at contact@ziteo.com.